To evaluate macular and peripapillary microvascular changes in systemic hypertension as measured by optical coherence tomography angiography technology
Not Applicable
- Conditions
- Health Condition 1: H350- Background retinopathy and retinalvascular changes
- Registration Number
- CTRI/2022/04/041654
- Lead Sponsor
- Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Hypertensive patients on medication for more than 5 years
2.Age: 30-60 years
3.BCVA � 6/12
Exclusion Criteria
1.Significant ocular media opacity (in order to maximize good quality images)
2.Grade 3 hypertensive retinopathy and above (according to Keith Wagener Barker classification).
3.Any other ocular pathology, e.g. macular edema, diabetic retinopathy, optic nerve disorders etc.
4.Any intraocular surgery
5.Any other systemic illness.
6.Refractive errors ( > +3 D, axial length (AL) >26.0 mm)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-To measure Macular and peripapillary OCTA parameters (VD, PD and FAZ dimensions) in systemic hypertension vs control group.Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method 1) Measurement of structural OCT Parameters (CMT, GC-IPL and RNFL thicknesses) <br/ ><br> in systemic hypertension vs normal control group. <br/ ><br>Timepoint: Baseline